Bolt Biotherapeutics Inc

NASDAQ:BOLT  
15.74
-0.29 (-1.81%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)566.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.33 Million
Adjusted EPS-$0.59
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Bolt Biotherapeutics Inc Stock, NASDAQ:BOLT

900 Chesapeake Drive, Redwood City, California 94063
United States of America
Phone: +1.650.665.9295
Number of Employees: 65

Description

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.